Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v10-FR | Version v8-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2018-01-22 | 2018-01-22 |
| Drug Identification Number | 01959034 | 01959034 |
| Brand name | ACT-HIB | ACT-HIB |
| Common or Proper name | Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate) | Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate) |
| Company Name | SANOFI PASTEUR LIMITED | SANOFI PASTEUR LIMITED |
| Ingredients | HAEMOPHILUS INFLUENZAE TYPE B-PRP TETANUS PROTEIN | HAEMOPHILUS INFLUENZAE TYPE B-PRP TETANUS PROTEIN |
| Strength(s) | 10 μG 30 μG | 10 μG 30 μG |
| Dosage form(s) | Powder For Solution | Powder For Solution |
| Route of administration | INTRAMUSCULAR | INTRAMUSCULAR |
| Packaging size | 5 x 0.5 mL vials / 5 fioles de 0,5 mL | 5 x 0.5 mL vials / 5 fioles de 0,5 mL |
| ATC code | J07AG | J07AG |
| ATC description | BACTERIAL VACCINES | BACTERIAL VACCINES |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2017-03-28 | 2017-03-28 |
| Actual start date | 2017-03-28 | 2017-03-28 |
| Estimated end date | 2017-11-15 | 2017-11-15 |
| Actual end date | 2018-01-18 | 2018-01-18 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | Act-Hib lot# UI880AA was released to the market on January 18, 2018. | The shortage has been resolved on January 18, 2018. |
| Health Canada comments |